- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
HRSA Rule Clarifies Hospitals' Ability to Purchase Orphan Drugs at Discount
A new regulation will allow certain hospitals to buy orphan drugs at deeply discounted prices if they're used to treat non-orphan conditions or diseases.
A new regulation will allow certain hospitals to buy orphan drugs at deeply discounted prices if they're used to treat non-orphan conditions or diseases.
The rule, issued earlier this week by the Health Resources and Services Administration, seeks to clarify a statute that excluded these facilities from purchasing drugs designated for a rare disease or condition at 340B prices.
The 2010 healthcare reform law expanded 340B eligibility to critical-access hospitals, sole community hospitals, rural referral centers and free-standing cancer hospitals. It also included a provision that excluded these four types of providers from using 340B pricing to buy orphan drugs, which are used to treat to rare diseases and conditions that affect fewer than 200,000 patients.
Read the full story here: http://bit.ly/1bmlhMC
Source: Modern Healthcare
The 340B federal drug discount program requires drug manufacturers to provide eligible healthcare providers with discounts on what are called covered outpatient drugs. The discounts are intended to aid providers that serve uninsured, indigent patient populations by permitting them to use the savings and revenue generated by the discounted prices to improve patient care and services.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
